Dingell, Waxman float "discussion draft" of US bill for safeguarding supply chain
This article was originally published in Scrip
Executive Summary
Four Congressional Democrats have released a "discussion draft" consisting of language for a long-awaited revised drug safety bill aimed at safeguarding the supply chain – both domestically and overseas - and supplying the US FDA with several new powers, including mandatory recall authority. The lawmakers would like the topic to become a priority, and want to work on refining the legislative draft, but it remains unclear whether any kind of proposed legislation could gather much support any time soon. Any bill would also face an uncertain future if Republicans take control of the House next year.